Prognostic roles of endostatin, matrix metalloproteinase-2 and 9 and tissue inhibitors of metalloproteinase-1 in advanced non-small cell lung cancer
Egyptian Journal of Hospital Medicine [The]. 2016; 63 (April): 206-209
em Inglês
| IMEMR
| ID: emr-176202
ABSTRACT
Background and aim of the work Previous studies verified that Endostatin, matrix metalloproteinase [MMP] -2 and -9, in addition to tissue inhibitors of metalloproteinase [TIMP] -1 may play a crucial role in prognosis of non-small cell lung cancer [NSCLC]. In this study we will investigate the changes in the pretreatment serum levels of these factors and to evaluate their clinical implication in patients with advanced non-small cell lung cancer [NSCLC]
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Inibidor Tecidual de Metaloproteinase-1
/
Metaloproteinase 2 da Matriz
/
Metaloproteinase 9 da Matriz
/
Endostatinas
/
Neoplasias Pulmonares
Limite:
Humanos
Idioma:
Inglês
Revista:
Egypt. J. Hosp. Med.
Ano de publicação:
2016
Similares
MEDLINE
...
LILACS
LIS